These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
327 related items for PubMed ID: 25462821
1. Surgical septal myectomy versus alcohol septal ablation: assessing the status of the controversy in 2014. Maron BJ, Nishimura RA. Circulation; 2014 Oct 28; 130(18):1617-24. PubMed ID: 25462821 [No Abstract] [Full Text] [Related]
2. Does myectomy convey survival benefit in hypertrophic cardiomyopathy? Woo A, Rakowski H. Heart Fail Clin; 2007 Jul 28; 3(3):275-88. PubMed ID: 17723936 [Abstract] [Full Text] [Related]
3. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. Valeti US, Nishimura RA, Holmes DR, Araoz PA, Glockner JF, Breen JF, Ommen SR, Gersh BJ, Tajik AJ, Rihal CS, Schaff HV, Maron BJ. J Am Coll Cardiol; 2007 Jan 23; 49(3):350-7. PubMed ID: 17239717 [Abstract] [Full Text] [Related]
4. The prognostic impact of septal myectomy in obstructive hypertrophic cardiomyopathy. Watkins H, McKenna WJ. J Am Coll Cardiol; 2005 Aug 02; 46(3):477-9. PubMed ID: 16053961 [No Abstract] [Full Text] [Related]
5. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, Gersh BJ, Ackerman MJ, McCully RB, Dearani JA, Schaff HV, Danielson GK, Tajik AJ, Nishimura RA. J Am Coll Cardiol; 2005 Aug 02; 46(3):470-6. PubMed ID: 16053960 [Abstract] [Full Text] [Related]
8. Hypertrophic obstructive cardiomyopathy: review of surgical treatment. Price J, Clarke N, Turer A, Quintana E, Mestres C, Huffman L, Peltz M, Wait M, Ring WS, Jessen M, Bajona P. Asian Cardiovasc Thorac Ann; 2017 Nov 02; 25(9):594-607. PubMed ID: 28901158 [Abstract] [Full Text] [Related]
9. Surgical management of obstructive hypertrophic cardiomyopathy: the gold standard. Brown ML, Schaff HV. Expert Rev Cardiovasc Ther; 2008 Jun 02; 6(5):715-22. PubMed ID: 18510487 [Abstract] [Full Text] [Related]
11. Alcohol septal ablation after failed surgical myectomy. Joyal D, Arab D, Chen-Johnston C, Leya F. Catheter Cardiovasc Interv; 2007 Jun 01; 69(7):999-1002. PubMed ID: 17525959 [Abstract] [Full Text] [Related]
12. Surgical myectomy versus alcohol septal ablation for obstructive hypertrophic cardiomyopathy: A propensity score-matched cohort. Nguyen A, Schaff HV, Hang D, Nishimura RA, Geske JB, Dearani JA, Lahr BD, Ommen SR. J Thorac Cardiovasc Surg; 2019 Jan 01; 157(1):306-315.e3. PubMed ID: 30279000 [Abstract] [Full Text] [Related]
13. Percutaneous septal ablation in a patient with recurrent outflow obstruction after previous surgical myectomy. Friedel I, Faber L, Horstrotte D. Minerva Cardioangiol; 2015 Dec 01; 63(6):591-4. PubMed ID: 26112280 [No Abstract] [Full Text] [Related]
14. Myectomy or alcohol septal ablation surgery and percutaneous intervention go another round. Heldman AW, Wu KC, Abraham TP, Cameron DE. J Am Coll Cardiol; 2007 Jan 23; 49(3):358-60. PubMed ID: 17239718 [No Abstract] [Full Text] [Related]
15. Outcome of repair of myocardial bridging at the time of septal myectomy. Kunkala MR, Schaff HV, Burkhart H, Sandhu GS, Spoon DB, Ommen SR, Sorajja P, Dearani JA. Ann Thorac Surg; 2014 Jan 23; 97(1):118-23. PubMed ID: 24075496 [Abstract] [Full Text] [Related]
16. Residual and recurrent gradients after septal myectomy for hypertrophic cardiomyopathy-mechanisms of obstruction and outcomes of reoperation. Cho YH, Quintana E, Schaff HV, Nishimura RA, Dearani JA, Abel MD, Ommen S. J Thorac Cardiovasc Surg; 2014 Sep 23; 148(3):909-15; discussion 915-6. PubMed ID: 24930617 [Abstract] [Full Text] [Related]
17. Selection of hypertrophic cardiomyopathy patients for myectomy or alcohol septal ablation. Lever HM. Anadolu Kardiyol Derg; 2006 Dec 23; 6 Suppl 2():27-30. PubMed ID: 17162266 [Abstract] [Full Text] [Related]
18. Current effectiveness and risks of isolated septal myectomy for hypertrophic obstructive cardiomyopathy. Smedira NG, Lytle BW, Lever HM, Rajeswaran J, Krishnaswamy G, Kaple RK, Dolney DO, Blackstone EH. Ann Thorac Surg; 2008 Jan 23; 85(1):127-33. PubMed ID: 18154797 [Abstract] [Full Text] [Related]
19. Controversies in cardiovascular medicine. Benefits of surgery in obstructive hypertrophic cardiomyopathy: bring septal myectomy back for European patients. Maron BJ, Yacoub M, Dearani JA. Eur Heart J; 2011 May 23; 32(9):1055-8. PubMed ID: 21324934 [Abstract] [Full Text] [Related]
20. Myectomy versus alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Afanasyev AV, Bogachev-Prokophiev AV, Kashtanov MG, Astapov DA, Zalesov AS, Budagaev SA, Sharifulin RM, Idov EM, Zheleznev SI. Interact Cardiovasc Thorac Surg; 2020 Aug 01; 31(2):158-165. PubMed ID: 32386304 [Abstract] [Full Text] [Related] Page: [Next] [New Search]